<DOC>
	<DOCNO>NCT01029821</DOCNO>
	<brief_summary>1 . The use LMWH follow open reduction internal fixation ankle fracture reduce number thrombus form . 2 . The rate clinically significant DVT equivalent two group .</brief_summary>
	<brief_title>Low-Molecular-Weight Heparin ( LMWH ) Deep Venous Thrombosis ( DVT ) Prophylaxis</brief_title>
	<detailed_description>Routine use thromboprophylaxis may treatment definitely increase healthcare cost . While prophylaxis may reduce number thrombus form exact number clinical significance unknown . This study seek answer question whether DVT prophylaxis low-molecular-weight heparin ( LMWH ) follow ORIF ankle fracture warrant .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>At least 18 year old Surgical ankle fracture able definitively treat one operation Younger 18 year age Other significant injury Known hypercoagulable state History bleed disorder History DVT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Low-Molecular-Weight-Heparin</keyword>
	<keyword>Open Reduction Internal Fixation</keyword>
	<keyword>Thromboprophylaxis</keyword>
</DOC>